• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Synthetic Biologics Inc

+ Add to Watchlist

SYN:US

1.5900 USD 0.0300 1.85%

As of 10:22:18 ET on 07/22/2014.

Snapshot for Synthetic Biologics Inc (SYN)

Open: 1.6200 Day's Range: 1.5300 - 1.6200 Volume: 153,624
Previous Close: 1.6200 52wk Range: 0.9500 - 3.6400 1-Yr Rtn: -3.05%

Stock Chart for SYN

No chart data available.
  • SYN:US 1.5700
  • 1D
  • 1M
  • 1Y
1.6200
Interactive SYN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SYN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2970
Est. EPS (USD) (12/2014) -0.2200
Est. PEG Ratio -
Market Cap (M USD) 94.69
Shares Outstanding (M) 58.45
30 Day Average Volume 562,257
Price/Book (mrq) 7.8832
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SYN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SYN

Synthetic Biologics, Inc. develops synthetic DNA-based therapeutics and disease-modifying medicines. The Company developed, or participated in developing, products to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis.

Jeffrey Lucero Riley "Jeff"President/CEOC Evan BallantyneCFO/Treasurer/Secretary
More Company Profile & Key Executives for SYN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil